Provectus Biopharmaceuticals’ Data on PV-10 to Be Presented at HemOnc Today Melanoma and Cutaneous Malignancies Annual Meeting
PV-10 Presentation Scheduled for 2:30 PM, Friday, April 10, 2015
Conference Runs April 10-11. 2015, at the Sheraton New York Times Square Hotel
April 07, 2015 06:00 AM Eastern Daylight Time
KNOXVILLE, Tenn.--( BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that Dr. Sanjiv Agarwala will present data on PV-10, the Company’s novel investigational drug for cancer, at the HemOnc Today Melanoma and Cutaneous Malignancies Annual Meeting on Friday, April 10, 2015 at the Sheraton New York Times Square Hotel.
The presentation on the use of PV-10 as an investigational treatment for melanoma is scheduled for 2:30 pm EDT. This will form part of the conference’s discussion of intralesional therapies and will precede a panel discussion in which Dr. Agarwala will also take part. Provectus will make the presentation available to the public on its website www.pvct.com at the time of the presentation. |
